Literature DB >> 2504480

Rocky Mountain spotted fever: a disease in need of microbiological concern.

D H Walker1.   

Abstract

Rocky Mountain spotted fever, a life-threatening tick-transmitted infection, is the most prevalent rickettsiosis in the United States. This zoonosis is firmly entrenched in the tick host, which maintains the rickettsiae in nature by transovarian transmission. Although the incidence of disease fluctuates in various regions and nationwide, the problems of a deceptively difficult clinical diagnosis and little microbiologic diagnostic effort persist. Many empiric antibiotic regimens lack antirickettsial activity. There is neither an effective vaccine nor a generally available assay that is diagnostic during the early stages of illness, when treatment is most effective. Microbiology laboratories that offer only the archaic retrospective Weil-Felix serologic tests should review the needs of their patients. Research microbiologists who tackle these challenging organisms have an array of questions to address regarding rickettsial surface composition, structure-function analysis, and pathogenic and immune mechanisms, as well as laboratory diagnosis.

Entities:  

Mesh:

Year:  1989        PMID: 2504480      PMCID: PMC358117          DOI: 10.1128/CMR.2.3.227

Source DB:  PubMed          Journal:  Clin Microbiol Rev        ISSN: 0893-8512            Impact factor:   26.132


  131 in total

1.  Rocky Mountain spotted fever.

Authors:  G T HARRELL
Journal:  Medicine (Baltimore)       Date:  1949-12       Impact factor: 1.889

2.  The sensitivity of various serologic tests in the diagnosis of Rocky Mountain spotted fever.

Authors:  J E Kaplan; L B Schonberger
Journal:  Am J Trop Med Hyg       Date:  1986-07       Impact factor: 2.345

3.  A microagglutination technique for detection and measurement of rickettsial antibodies.

Authors:  P Fiset; R A Ormsbee; R Silberman; M Peacock; S H Spielman
Journal:  Acta Virol       Date:  1969-01       Impact factor: 1.162

4.  Rocky Mountain spotted fever in children.

Authors:  R E Haynes; D Y Sanders; H G Cramblett
Journal:  J Pediatr       Date:  1970-05       Impact factor: 4.406

5.  Haemolysis with rickettsiosis and glucose-6-phosphate dehydrogenase deficiency.

Authors:  D H Walker; D L Radisch; H N Kirkman
Journal:  Lancet       Date:  1983-07-23       Impact factor: 79.321

6.  Electron microscopy of surface structures of Rickettsia prowazeki stained with ruthenium red.

Authors:  V L Popov; V F Ignatovich
Journal:  Acta Virol       Date:  1976-10       Impact factor: 1.162

7.  Fatal Rocky Mountain spotted fever.

Authors:  M A Hattwick; H Retailliau; R J O'Brien; M Slutzker; R E Fontaine; B Hanson
Journal:  JAMA       Date:  1978-09-29       Impact factor: 56.272

8.  External layers of Rickettsia prowazekii and Rickettsia rickettsii: occurrence of a slime layer.

Authors:  D J Silverman; C L Wisseman; A D Waddell; M Jones
Journal:  Infect Immun       Date:  1978-10       Impact factor: 3.441

9.  Human endothelial cell culture plaques induced by Rickettsia rickettsii.

Authors:  D H Walker; W T Firth; C J Edgell
Journal:  Infect Immun       Date:  1982-07       Impact factor: 3.441

10.  Correlation of rickettsial titers, circulating endotoxin, and clinical features in Rocky Mountain spotted fever.

Authors:  L G Kaplowitz; J V Lange; J J Fischer; D H Walker
Journal:  Arch Intern Med       Date:  1983-06
View more
  26 in total

1.  Molecular typing of isolates of Rickettsia rickettsii by use of DNA sequencing of variable intergenic regions.

Authors:  Sandor E Karpathy; Gregory A Dasch; Marina E Eremeeva
Journal:  J Clin Microbiol       Date:  2007-06-06       Impact factor: 5.948

Review 2.  Laboratory diagnosis of rickettsioses: current approaches to diagnosis of old and new rickettsial diseases.

Authors:  B La Scola; D Raoult
Journal:  J Clin Microbiol       Date:  1997-11       Impact factor: 5.948

3.  Failure of a heterologous recombinant Sca5/OmpB protein-based vaccine to elicit effective protective immunity against Rickettsia rickettsii infections in C3H/HeN mice.

Authors:  Sean P Riley; Marissa M Cardwell; Yvonne G Y Chan; Ludovic Pruneau; Fabio Del Piero; Juan J Martinez
Journal:  Pathog Dis       Date:  2015-10-29       Impact factor: 3.166

4.  Molecular basis of immunity to rickettsial infection conferred through outer membrane protein B.

Authors:  Yvonne Gar-Yun Chan; Sean Phillip Riley; Emily Chen; Juan José Martinez
Journal:  Infect Immun       Date:  2011-03-28       Impact factor: 3.441

Review 5.  Pathogenesis of Rickettsial Diseases: Pathogenic and Immune Mechanisms of an Endotheliotropic Infection.

Authors:  Abha Sahni; Rong Fang; Sanjeev K Sahni; David H Walker
Journal:  Annu Rev Pathol       Date:  2018-08-27       Impact factor: 23.472

6.  In vitro susceptibilities of spotted fever group rickettsiae and Coxiella burnetti to clarithromycin.

Authors:  M Maurin; D Raoult
Journal:  Antimicrob Agents Chemother       Date:  1993-12       Impact factor: 5.191

7.  Gene sequence-based criteria for identification of new rickettsia isolates and description of Rickettsia heilongjiangensis sp. nov.

Authors:  Pierre-Edouard Fournier; J Stephen Dumler; Gilbert Greub; Jianzhi Zhang; Yimin Wu; Didier Raoult
Journal:  J Clin Microbiol       Date:  2003-12       Impact factor: 5.948

8.  In vitro susceptibilities of Coxiella burnetii, Rickettsia rickettsii, and Rickettsia conorii to the fluoroquinolone sparfloxacin.

Authors:  D Raoult; P Bres; M Drancourt; G Vestris
Journal:  Antimicrob Agents Chemother       Date:  1991-01       Impact factor: 5.191

9.  Limited transcriptional responses of Rickettsia rickettsii exposed to environmental stimuli.

Authors:  Damon W Ellison; Tina R Clark; Daniel E Sturdevant; Kimmo Virtaneva; Ted Hackstadt
Journal:  PLoS One       Date:  2009-05-19       Impact factor: 3.240

10.  Fatal spotted fever rickettsiosis, Minas Gerais, Brazil.

Authors:  Márcio Antonio Moreira Galvâo; J Stephen Dumler; Cláudio Lísias Mafra; Simone Berger Calic; Chequer Buffe Chamone; Gracco Cesarino Filho; Juan Pablo Olano; David H Walker
Journal:  Emerg Infect Dis       Date:  2003-11       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.